The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (17 analysts) rates it buy, with a mean price target of $310. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
AeroVironment, Inc.
AVAV · Nasdaq · USD · Market cap $7.5B · 1,456 employees
AeroVironment, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
AeroVironment, Inc. holds its Markdown at $147.07. The statistical read favours the sellers, held for 18 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 18 days |
| Price at the screen | $147.07 |
| Valuation | N/A trailing · 33.40 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.41 |
Five Screens, Shown in Full
Does not pass. Prohibited business activity: Aerospace & Defense
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited business activity: Aerospace & Defense | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Conscience OverlayThe quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on AFSC Investigate / American Friends Service Committee / Don’t Buy Into Occupation — category: Corporate Complicity Report / Annex 2 Company List. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
The Fair Value Range
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 6.4% margin of safety to the base estimate.
Third-party analyst targets: 19 covering, consensus Buy. The average target sits +53% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsMilitary drones spark excitement yet breach our line
Picture a small unmanned aircraft slipping over contested ground, feeding live video to troops who never see the operator. AeroVironment builds those systems, and demand is exploding with revenue up 133 percent. Yet the company posts a 13 percent loss margin and negative return on equity, while shares trade at 31 times forward earnings.
We pass without hesitation. The ethical screen flags aerospace and defence work as prohibited, regardless of growth rates or the 19 analysts who still rate the shares a buy. Fair value sits only modestly above the current price, but that gap means nothing once the screen is triggered.
High cyclical exposure in government contracts adds further caution, as any shift in budgets could widen the losses already visible on the income statement. The market may like the story, yet our rules are clear on this sector. Analysis, not advice.
| Forward P/E | 33.4xcheap for a company growing this fast |
| EPS, trailing | -5.41 |
| EPS, forward | 4.40 |
| Revenue growth | +133.3%growing very fast |
| Profit margin | -13.4%currently unprofitable |
| Return on equity | -10.0%not currently earning a positive return on equity |
| FCF yield | -3.36% |
| Debt to equity | 0.19minimal debt: a conservative balance sheet |
| Current ratio | 4.30comfortably covers its short-term bills |
| Beta | 1.41moves a little more than the market |
| Short interest, float | 0.10% |
| 52-week range | 135.20 - 417.86 |
| Market cap | $7.5B |
| Employees | 1,456 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeAVAV trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (17 analysts) rates it buy, with a mean price target of $310. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (17 analysts) rates it buy, with a mean price target of $310. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (17 analysts) rates it buy, with a mean price target of $310. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (17 analysts) rates it buy, with a mean price target of $310. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (17 analysts) rates it buy, with a mean price target of $310. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (17 analysts) rates it buy, with a mean price target of $310. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (17 analysts) rates it buy, with a mean price target of $310. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 13.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (17 analysts) rates it buy, with a mean price target of $310. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 20.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (17 analysts) rates it buy, with a mean price target of $310. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Shackley Brian Charles | SVP, Chief Accounting Officer | S - Sale | 205 | $41,381 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $166.45 | +4.4% | · | $1,044 | +4.4% |
| 2 months | $179.72 | -3.3% | · | $967 | -3.3% |
| 3 months | $211.88 | -18.0% | · | $820 | -18.0% |
| 6 months | $249.75 | -30.4% | · | $696 | -30.4% |
| 1 year | $189.62 | -8.4% | · | $917 | -8.4% |
| 2 years | $204.89 | -15.2% | · | $848 | -15.2% |
| 3 years | $97.95 | +77.4% | · | $1,774 | +77.4% |
| 5 years | $112.49 | +54.5% | · | $1,545 | +54.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever AVAV does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.